INHCC Mission
The mission of the International NeuroHIV Cure Consortium (INHCC) is to provide cutting-edge investigation and expertise in central nervous system (CNS) aspects of HIV infection relevant to pathogenesis, treatment, and HIV remission, or 'cure.' Beginning with our first project in 2009 to evaluate the neurological implications of acute HIV infection, the group has grown to now encompass investigation into a broad array of early infection and cure strategy work. The consortium was established in 2014 to facilitate scientific exchange among investigators in a diverse array of fields and to leverage all aspects of the research portfolio through multidisciplinary studies during acute and chronic HIV infection and HIV remission studies.
|
INHCC News Dr Rob Paul named Curator's Distinguished Professor at UMSL Coming Up! December 13-16 2022: HIV Persistence During Therapy: Reservoirs & Eradication Strategies Workshop, Miami FL INHCC Fellow, Dr Ferron Ocampo, visits in US 2023 INHCC Fellow, Dr Kathryn Holroyd arrived Bangkok! 
Drs Katie Holroyd & Ferron Ocampo in Bangkok
|
MAJ McGuckin Wuertz of the MHRP mentors INHCC mentee, Eunice Chukwunyere in the lab!
Fireside Chat: INHCC Co-Director Serena Spudich & NIMH Director Joshua Gordon
|
Consortium Leadership
Serena Spudich MD, MA
Yale University
Denise Hsu BSc (Med) MBBS, PhD
US Military HIV Research Program (MHRP)
INHCC work is sponsored by NIH, NIMH, NINDS, NIAID, the Henry Jackson Foundation (HJF) and the Walter Reed Army Institute of Research (WRAIR)
